Evidence map›Paper›PMID 29497879›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2018

Community-acquired Clostridium difficile infection in Serbian pediatric population.

Stojanović Predrag, Kocić Branislava, Stojanović Nikola, Radulovic Niko, Stojanović-Radić Zorica, Dobrila Stanković-Đorđević

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Journal of medical microbiology · 2024
    Review
  2. Analysis of risk factors for community-acquiredTranslational pediatrics · 2023
    Article
  3. Article
  4. Recurrent community-acquired Clostridium(Clostridioides)difficile infection in Serbianchildren.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  5. Gut pathogens · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Stojanović PredragFaculty of Medicine, University of Niš, Zorana Đinđića 81, Niš, 18000, Serbia. pedjamicro@sezampro.rs.
Kocić BranislavaFaculty of Medicine, University of Niš, Zorana Đinđića 81, Niš, 18000, Serbia.
Stojanović NikolaFaculty of Medicine, University of Niš, Zorana Đinđića 81, Niš, 18000, Serbia.
Radulovic NikoDepartment of Chemistry, Faculty of Science and Mathematics, University of Niš, Višegradska 33, Niš, 18000, Serbia.
Stojanović-Radić ZoricaDepartment of Biology and Ecology, Faculty of Science and Mathematics, University of Niš, Višegradska 33, Niš, 18000, Serbia.
Dobrila Stanković-ĐorđevićFaculty of Medicine, University of Niš, Zorana Đinđića 81, Niš, 18000, Serbia.
University of Nis · RS

Funding

Ministry of Education, Science and Technological Development of Serbia [Projects No. 172061] Projects No. 172061
6 · The paper itself

Abstract

Carriage of Clostridium (C.) difficile in the intestinum of children, as well as its role in the disease (diarrhea) onset, is still controversial. The aim of this study is to investigate the community-acquired Clostridium difficile infection (CA-CDI) in Serbian pediatric population and to describe the basic clinical characteristics and risk factors for CA-CDI occurrence in Serbian pediatric population. The data obtained from 63 Serbian pediatric patients with CA-CDI and from control group of 126 children with community-acquired diarrhea, whose stool specimens were negative for C. difficile and toxins A/B, were mutually compared. In the current work, we found that children with CA-CDI display a significantly less severe disease clinical presentation than children with diarrheas of other origin. Lethal outcome was noted in two cases, but in children with severe underlying diseases (Crohn's disease and leukemia). By using the multivariate statistical regression model, the following statistically significant risk factors for community-acquired C. difficile-associated diarrhea development were determined: previous application of laxatives (OR = 0.199, CI 0.55-0.79, p = 0.015), general antibiotic use during the previous 2 months (OR = 0.05, CI 0.02-0.17, p < 0.001), and specifically the use of penicillins (OR = 0.112, CI 0.04-0.31, p < 0.0001) and cephalosporins (OR = 0.16, CI 40.06-0.44, p < 0.0001). Antibiotics from the groups of cephalosporins and penicillins were found to be the most important independent risk factors. Laxative application plays a significant role in the community-acquired Clostridium difficile infections in children, with mechanisms that are not completely understood.

Indexed as

Anti-Bacterial AgentsCase-Control StudiesCephalosporinsChildChild, PreschoolClostridioides difficileClostridium InfectionsCommunity-Acquired InfectionsCross InfectionDiarrheaFemaleHumansInfantMalePenicillinsProspective StudiesAnti-Bacterial AgentsCephalosporinsPenicillinsChildrenClostridium difficileCommunity-acquired diarrheaDiarrhea

Identifiers

PMID29497879
OpenAlexW2794067267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.